17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil
We evaluated the duration of neutralizing antibodies and the status of 17DD vaccine–specific T- and B-cell memory following primary and revaccination regimens for yellow fever (YF) in Brazil. We observed progressive decline of plaque-reduction neutralization test (PRNT) seropositivity and of the lev...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2019-08-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/25/8/18-1432_article |
id |
doaj-1b4bf57455084e988dd27f6a3148665b |
---|---|
record_format |
Article |
spelling |
doaj-1b4bf57455084e988dd27f6a3148665b2020-11-25T00:41:48ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592019-08-012581511152110.3201/eid2508.18143217DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, BrazilOlindo Assis Martins-FilhoVanessa Peruhype-MagalhāesJordana Grazziela Coelho-dos-ReisLis Ribeiro AntonelliChristiane Costa-PereiraElaine SpezialiLaise Rodrigues ReisJandira Aparecida LemosJosé Geraldo Leite RibeiroLuiz Antônio Bastos CamachoMaria de Lourdes de Sousa MaiaSheila Maria Barbosa de LimaMarisol SimõesReinaldo de Menezes MartinsAkira HommaLuiz Cosme Cota MalaquiasPedro Luiz TauilPedro Fernando Costa VasconcelosAlessandro Pecego Martins RomanoCarla Magda DominguesAndréa Teixeira-CarvalhoAna Carolina Campi-AzevedoWe evaluated the duration of neutralizing antibodies and the status of 17DD vaccine–specific T- and B-cell memory following primary and revaccination regimens for yellow fever (YF) in Brazil. We observed progressive decline of plaque-reduction neutralization test (PRNT) seropositivity and of the levels of effector memory CD4+ and CD8+ T cells, as well as interferon-γ+CD8+ T cells, 10 years after primary vaccination. Revaccination restored PRNT seropositivity as well as the levels of effector memory CD4+, CD8+, and interferon-γ+CD8+ T cells. Moreover, secondary or multiple vaccinations guarantee long-term persistence of PRNT positivity and cell-mediated memory 10 years after booster vaccination. These findings support the relevance of booster doses to heighten the 17DD-YF–specific immune response to guarantee the long-term persistence of memory components. Secondary or multiple vaccinations improved the correlates of protection triggered by 17DD-YF primary vaccination, indicating that booster regimens are needed to achieve efficient immunity in areas with high risk for virus transmission.https://wwwnc.cdc.gov/eid/article/25/8/18-1432_articleyellow fever17DD vaccineneutralizing antibodiesmemory CD8+ T-cellsvector-borne infectionsviruses |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Olindo Assis Martins-Filho Vanessa Peruhype-Magalhāes Jordana Grazziela Coelho-dos-Reis Lis Ribeiro Antonelli Christiane Costa-Pereira Elaine Speziali Laise Rodrigues Reis Jandira Aparecida Lemos José Geraldo Leite Ribeiro Luiz Antônio Bastos Camacho Maria de Lourdes de Sousa Maia Sheila Maria Barbosa de Lima Marisol Simões Reinaldo de Menezes Martins Akira Homma Luiz Cosme Cota Malaquias Pedro Luiz Tauil Pedro Fernando Costa Vasconcelos Alessandro Pecego Martins Romano Carla Magda Domingues Andréa Teixeira-Carvalho Ana Carolina Campi-Azevedo |
spellingShingle |
Olindo Assis Martins-Filho Vanessa Peruhype-Magalhāes Jordana Grazziela Coelho-dos-Reis Lis Ribeiro Antonelli Christiane Costa-Pereira Elaine Speziali Laise Rodrigues Reis Jandira Aparecida Lemos José Geraldo Leite Ribeiro Luiz Antônio Bastos Camacho Maria de Lourdes de Sousa Maia Sheila Maria Barbosa de Lima Marisol Simões Reinaldo de Menezes Martins Akira Homma Luiz Cosme Cota Malaquias Pedro Luiz Tauil Pedro Fernando Costa Vasconcelos Alessandro Pecego Martins Romano Carla Magda Domingues Andréa Teixeira-Carvalho Ana Carolina Campi-Azevedo 17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil Emerging Infectious Diseases yellow fever 17DD vaccine neutralizing antibodies memory CD8+ T-cells vector-borne infections viruses |
author_facet |
Olindo Assis Martins-Filho Vanessa Peruhype-Magalhāes Jordana Grazziela Coelho-dos-Reis Lis Ribeiro Antonelli Christiane Costa-Pereira Elaine Speziali Laise Rodrigues Reis Jandira Aparecida Lemos José Geraldo Leite Ribeiro Luiz Antônio Bastos Camacho Maria de Lourdes de Sousa Maia Sheila Maria Barbosa de Lima Marisol Simões Reinaldo de Menezes Martins Akira Homma Luiz Cosme Cota Malaquias Pedro Luiz Tauil Pedro Fernando Costa Vasconcelos Alessandro Pecego Martins Romano Carla Magda Domingues Andréa Teixeira-Carvalho Ana Carolina Campi-Azevedo |
author_sort |
Olindo Assis Martins-Filho |
title |
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil |
title_short |
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil |
title_full |
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil |
title_fullStr |
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil |
title_full_unstemmed |
17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil |
title_sort |
17dd yellow fever revaccination and heightened long-term immunity in populations of disease-endemic areas, brazil |
publisher |
Centers for Disease Control and Prevention |
series |
Emerging Infectious Diseases |
issn |
1080-6040 1080-6059 |
publishDate |
2019-08-01 |
description |
We evaluated the duration of neutralizing antibodies and the status of 17DD vaccine–specific T- and B-cell memory following primary and revaccination regimens for yellow fever (YF) in Brazil. We observed progressive decline of plaque-reduction neutralization test (PRNT) seropositivity and of the levels of effector memory CD4+ and CD8+ T cells, as well as interferon-γ+CD8+ T cells, 10 years after primary vaccination. Revaccination restored PRNT seropositivity as well as the levels of effector memory CD4+, CD8+, and interferon-γ+CD8+ T cells. Moreover, secondary or multiple vaccinations guarantee long-term persistence of PRNT positivity and cell-mediated memory 10 years after booster vaccination. These findings support the relevance of booster doses to heighten the 17DD-YF–specific immune response to guarantee the long-term persistence of memory components. Secondary or multiple vaccinations improved the correlates of protection triggered by 17DD-YF primary vaccination, indicating that booster regimens are needed to achieve efficient immunity in areas with high risk for virus transmission. |
topic |
yellow fever 17DD vaccine neutralizing antibodies memory CD8+ T-cells vector-borne infections viruses |
url |
https://wwwnc.cdc.gov/eid/article/25/8/18-1432_article |
work_keys_str_mv |
AT olindoassismartinsfilho 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT vanessaperuhypemagalhaes 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT jordanagrazzielacoelhodosreis 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT lisribeiroantonelli 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT christianecostapereira 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT elainespeziali 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT laiserodriguesreis 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT jandiraaparecidalemos 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT josegeraldoleiteribeiro 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT luizantoniobastoscamacho 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT mariadelourdesdesousamaia 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT sheilamariabarbosadelima 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT marisolsimoes 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT reinaldodemenezesmartins 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT akirahomma 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT luizcosmecotamalaquias 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT pedroluiztauil 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT pedrofernandocostavasconcelos 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT alessandropecegomartinsromano 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT carlamagdadomingues 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT andreateixeiracarvalho 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil AT anacarolinacampiazevedo 17ddyellowfeverrevaccinationandheightenedlongtermimmunityinpopulationsofdiseaseendemicareasbrazil |
_version_ |
1725285550059945984 |